The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa

Acta Oto-Laryngologica

Volumn 117, Issue 6, 1997, Pages 851-855

  Browning, Simon ^a   Housley, David ^a   Richards, Roy ^a   Eccles, Ronald ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Airway resistance; Lysozyme; Nasal lavage; Oxymetazoline

Indexed keywords

LYSOZYME; OXYMETAZOLINE;

ADULT; AIRWAY RESISTANCE; ARTICLE; CHOLINERGIC ACTIVITY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; NORMAL HUMAN; NOSE MUCOSA; NOSE MUCUS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SECRETION; RHINOMANOMETRY;

EID: 0030691048     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709114213     Document Type: Article

References (10)

1. Graf P. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology 1996; 34: 9-13.
2. Svensson C, Pipkorn U, Alkner U, Baumgarten CR, Persson CGA. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 1992; 22: 411-6.
3. Raphael GD, Jeney EV, Baraniuk JN, Kim I, Meredith SD, Kaliner MA. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J Clin Invest 1989; 84: 1528-35.
4. Housley DG, Eccles R, Richards RJ. Gender difference in the concentration of the antioxidant uric acid in human nasal lavage. Acta Otolaryngol (Stockh) 1996; 116: 751-4.
5. Smolelis AN, Harstel SE. The determination of lysozyme. J Bacteriol 1949; 58: 731-9.
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
7. Raphael GD, Meredith SD, Baraniuk JN, Druce HM, Banks SM, Kaliner MA. The pathophysiology of rhinitis II. Assessment of the sources of protein in histamine-induced secretions. Am Rev Respir Dis 1989; 139: 791-800.
8. Bende M, Hansell P, Intaglietta M, Arfors KE. Effect of oxymetazoline nose drops on vascular-permea bility of the nasal-mucosa in the rabbit after provocation with leukotriene-b4. J Oto Rhino Laryngol 1992; 54: 270-4.
9. Bende M, Loth S. Vascular effects of topical oxymetazoline on human nasal mucosa. J Laryngol Otol 1986; 100: 285-8.
10. Andersson KE, Bende M. Adrenoceptors in the control of human nasal mucosal blood flow. Ann Otol Rhinol Laryngol 1984; 93: 179-82.